Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,420.50 DKK | +1.00% |
|
+1.86% | -4.82% |
16/07 | Genmab A/S Announces Sales Results of Darzalex for Second Quarter of 2025 | CI |
16/07 | Genmab says net sales of Darzalex in Q2 $3,539 mln | RE |
Main competitors
P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
---|---|---|---|---|---|---|---|---|---|
13.78x | 2.16x | -0.87x | 2.73x | 7.69x | 8.39x | -.--% | 1.35TCr | ||
49.61x | 5.42x | -2.45x | 8.53x | 37.82x | 39.22x | -.--% | 3.47TCr | ||
18.99x | 3.37x | 0.7x | 4.74x | 13.07x | 15.33x | 1.52% | 3.14TCr | ||
-23.89x | 1.29x | -0.52x | 5.93x | -9.68x | -8.99x | -.--% | 2.77TCr | ||
-66.37x | - | -2.28x | - | -67.15x | -65.43x | -.--% | 2.1TCr | ||
-19.64x | 58.12x | 4.48x | 43.76x | -21.52x | -21.26x | -.--% | 1.99TCr | ||
1188.59x | 15.01x | -10.23x | 29.12x | 340.45x | 1589.07x | -.--% | 1.44TCr | ||
25.79x | 2.15x | 1.09x | 4.53x | 13.16x | 16.81x | -.--% | 1.41TCr | ||
19.46x | 4.38x | 0.63x | 4.69x | 13.44x | 14.07x | -.--% | 1.22TCr | ||
-118.89x | 25.88x | -0.9x | 36.95x | -200.74x | -117.87x | -.--% | 1.03TCr | ||
353.05x | - | -3.1x | 21.02x | - | 250.09x | - | 891.67Cr | ||
-27.01x | 14.63x | 0.65x | 10.49x | -18.64x | -20.98x | -.--% | 765.95Cr | ||
-45.5x | 7.38x | 5.06x | 6.6x | -60.3x | -53.88x | -.--% | 732.55Cr | ||
24.7x | 6.35x | 1x | - | - | - | - | 614.21Cr | ||
62.62x | 2.14x | -2.46x | 3.68x | 16.72x | 30.46x | 0.29% | 613.67Cr | ||
-17.26x | 6.92x | -0.66x | - | -18.42x | -15.94x | -.--% | 613.61Cr | ||
30.22x | 5.49x | 0.31x | 10.06x | 31.51x | 34.09x | -.--% | 600.74Cr | ||
-40.72x | 20.02x | 0.94x | 16.31x | -73.15x | -54.51x | -.--% | 516.11Cr | ||
-7.59x | - | -0.28x | - | - | - | -.--% | 471.77Cr | ||
Average | 74.73x | 11.29x | -0.47x | 13.94x | 0.26x | 96.39x | 0.11% | 1.36TCr | |
Weighted average by Cap. | 75.84x | 11.12x | -0.68x | 13.31x | 8.90x | 96.02x | 0.2% |
- Stock Market
- Equities
- GMAB Stock
- Sector Genmab A/S
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition